Newborn Health Initiative's Andy Rosenberg Stresses Need for New Therapy Innovations at the 2017 Infant Health Policy Summit
Today, Newborn Health Initiative Director Andy Rosenberg delivered a presentation at the National Coalition for Infant Health's 2017 Infant Health Policy Summit. His powerful story in his opening remarks underscored the urgent need to promote innovation in drug therapies for our healthcare system's most vulnerable constituency - our newborn babies. "When I first became involved with the Initiative, I fully expected to learn a lot, and was prepared to be moved by the experience of working on such an emotional issue," said Rosenberg. "What I didn’t really expect, however, and what I somehow failed to see, was that I would find myself becoming personally invested because I myself was, a neonate patient."